Option Care Health Inc (OPCH)
NASDAQ:OPCH
Want to see OPCH full AI Analyst Report?
OPCH Stock Chart & Stats
$28.82
-$0.14(-0.58%)
At close: 4:00 PM EST
$28.82
-$0.14(-0.58%)
Day’s Range― - ―
52-Week Range$18.01 - $36.80
Previous CloseN/A
Volume256.90K
Average Volume (3M)1.62M
Market Cap
$3.22B
Enterprise Value$3.04B
Total Cash (Recent Filing)$177.32M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)23.3
Beta0.38
Next Earnings
Aug 05, 2026EPS Estimate
0.43Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.29
Shares Outstanding157,027,510
10 Day Avg. Volume1,704,608
30 Day Avg. Volume1,619,108
Financial Highlights & Ratios
PEG Ratio6.12
Price to Book (P/B)3.89
Price to Sales (P/S)0.91
P/FCF Ratio19.98
Enterprise Value/Market Cap0.94
Enterprise Value/Revenue0.54
Enterprise Value/Gross Profit2.98
Enterprise Value/Ebitda7.50
Forecast
1Y Price Target
$30.73Price Target Upside6.62% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
EPS Forecast (FY)1.83
Revenue Forecast (FY)$5.74B
Bulls Say, Bears Say
Bulls Say
Guidance And Cash FlowCompany affirmed financial guidance and expects a meaningful increase in cash flow from operations, supporting operational stability and funding for growth initiatives.
Product Portfolio And PipelineReliance on a single therapy has been materially reduced and ongoing pipeline activity with new drug introductions positions the company to resume stronger revenue growth and expand margins.
Share Repurchases And Capital AllocationBoard approved a meaningful increase in the share repurchase authorization, signaling stronger focus on returning capital to shareholders and confidence in future cash generation.
Bears Say
Inventory Unwind And SeasonalityUnwinding of a prior inventory-driven sales boost and seasonal patient behavior create tougher comparisons that may soften reported revenue growth and limit upside surprises.
Pricing Pressure From Biosimilars And PolicyPricing changes and increased biosimilar competition are likely to reduce gross profits for affected therapies and compress overall margins.
Therapy-specific Revenue PressureStelara-related headwinds are expected to create a revenue and gross profit drag that could pressure near-term results and cause uneven quarterly performance.
Option Care Health News
OPCH FAQ
What was Option Care Health Inc’s price range in the past 12 months?
Option Care Health Inc lowest stock price was $18.01 and its highest was $36.80 in the past 12 months.
What is Option Care Health Inc’s market cap?
Option Care Health Inc’s market cap is $3.22B.
When is Option Care Health Inc’s upcoming earnings report date?
Option Care Health Inc’s upcoming earnings report date is Aug 05, 2026 which is in 87 days.
How were Option Care Health Inc’s earnings last quarter?
Option Care Health Inc released its earnings results on Apr 30, 2026. The company reported $0.4 earnings per share for the quarter, beating the consensus estimate of $0.371 by $0.029.
Is Option Care Health Inc overvalued?
According to Wall Street analysts Option Care Health Inc’s price is currently Undervalued.
Does Option Care Health Inc pay dividends?
Option Care Health Inc does not currently pay dividends.
What is Option Care Health Inc’s EPS estimate?
Option Care Health Inc’s EPS estimate is 0.43.
How many shares outstanding does Option Care Health Inc have?
Option Care Health Inc has 157,027,510 shares outstanding.
What happened to Option Care Health Inc’s price movement after its last earnings report?
Option Care Health Inc reported an EPS of $0.4 in its last earnings report, beating expectations of $0.371. Following the earnings report the stock price went down -24.339%.
Which hedge fund is a major shareholder of Option Care Health Inc?
Currently, no hedge funds are holding shares in OPCH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Option Care Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$30.73 (6.62% Upside)
$30.73 (6.62% Upside)
Blogger Sentiment
Bullish
OPCH Sentiment 67%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 845.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $706.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 9.2%
Last 30 Days ▲ 8.2%
Last 30 Days ▲ 8.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-9.99%
12-Months-Change
Fundamentals
Return on Equity
15.28%
Trailing 12-Months
Asset Growth
2.16%
Trailing 12-Months
Company Description
Option Care Health Inc
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
OPCH Company Deck
OPCH Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call described a mixed quarter: strong execution in acute therapies, clinic utilization growth, patient satisfaction and preserved profitability guidance were offset by a material chronic portfolio reset (notably Stelara/CID), a larger-than-anticipated $55 million gross profit headwind, patient census declines and related revenue shortfall. Management communicated targeted commercial and operational actions, expanded liquidity, and confidence that the CID reset is largely a one-time event, but rebuilding chronic census and recovering revenue momentum will take time.View all OPCH earnings summariesOPCH Stock 12 Month Forecast
Average Price Target
$30.73
▲(6.62% Upside)
Technical Analysis
Addus Homecare
―
Chemed
―
National Healthcare
―
Surgery Partners
―
Aveanna Healthcare Holdings
―
Ownership Overview
1.23% Insiders
37.23% Mutual Funds
10.72% Other Institutional Investors
24.29% Public Companies and
Individual Investors